Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Marsoni

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Communications Medicine|April 24, 2025
Clinical utility and future perspectives of liquid biopsy in colorectal cancerGiorgio Patelli, Luca Lazzari, Giovanni Crisafulli, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Stain normalization matters: impact on feature relevance and classifier performance in mCRC therapy response predictionGiulia Nicoletti, Debora Cafaro, Federica Cruciani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2024
How to Test <i>HER2</i> for Predicting Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer? Evidence From the Secondary Analysis of Biomarkers of CALGB/SWOG 80405Andrea Sartore-Bianchi, Silvia Marsoni, Alessio Amatu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2010
Role of cetuximab in the treatment of patients with NSCLC: are we throwing out the baby with the bath water?Irene Floriani, Marina Chiara Garassino, Massimo Broggini, et al.
British Journal of Cancer|March 10, 2022
Liquid biopsies to monitor and direct cancer treatment in colorectal cancerGianluca Mauri, Pietro Paolo Vitiello, Alberto Sogari, et al.
Nature Reviews. Clinical Oncology|April 17, 2021
Precision oncology in metastatic colorectal cancer - from biology to medicineFederica Di Nicolantonio, Pietro Paolo Vitiello, Silvia Marsoni, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
AI-Driven Pathomics for Predicting Chemotherapy Response in Metastatic Colorectal Cancer: A Transfer Learning Approach with Attention-Based Multiple Instance LearningFederica Cruciani, Giulia Nicoletti, Debora Cafaro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2006
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosingCristiana Sessa, Lucia Viganò, Giacomo Grasselli, et al.
Cell Reports. Medicine|September 11, 2024
Early-onset cancers: Biological bases and clinical implicationsGianluca Mauri, Giorgio Patelli, Andrea Sartore-Bianchi, et al.
Acta Oncologica (Stockholm, Sweden)|December 28, 2010
A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignanciesElisa Gallerani, Jean Bauer, Dagmar Hess, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Communications Medicine|April 24, 2025
Clinical utility and future perspectives of liquid biopsy in colorectal cancerGiorgio Patelli, Luca Lazzari, Giovanni Crisafulli, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Stain normalization matters: impact on feature relevance and classifier performance in mCRC therapy response predictionGiulia Nicoletti, Debora Cafaro, Federica Cruciani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2024
How to Test <i>HER2</i> for Predicting Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer? Evidence From the Secondary Analysis of Biomarkers of CALGB/SWOG 80405Andrea Sartore-Bianchi, Silvia Marsoni, Alessio Amatu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2010
Role of cetuximab in the treatment of patients with NSCLC: are we throwing out the baby with the bath water?Irene Floriani, Marina Chiara Garassino, Massimo Broggini, et al.
British Journal of Cancer|March 10, 2022
Liquid biopsies to monitor and direct cancer treatment in colorectal cancerGianluca Mauri, Pietro Paolo Vitiello, Alberto Sogari, et al.
Nature Reviews. Clinical Oncology|April 17, 2021
Precision oncology in metastatic colorectal cancer - from biology to medicineFederica Di Nicolantonio, Pietro Paolo Vitiello, Silvia Marsoni, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
AI-Driven Pathomics for Predicting Chemotherapy Response in Metastatic Colorectal Cancer: A Transfer Learning Approach with Attention-Based Multiple Instance LearningFederica Cruciani, Giulia Nicoletti, Debora Cafaro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2006
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosingCristiana Sessa, Lucia Viganò, Giacomo Grasselli, et al.
Cell Reports. Medicine|September 11, 2024
Early-onset cancers: Biological bases and clinical implicationsGianluca Mauri, Giorgio Patelli, Andrea Sartore-Bianchi, et al.
Acta Oncologica (Stockholm, Sweden)|December 28, 2010
A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignanciesElisa Gallerani, Jean Bauer, Dagmar Hess, et al.
Pageof 9